Emerging treatment approaches in acute lymphoblastic and acute myeloid leukemias by Thomas X

Get full text

Fighting Power: Interpretive Issues. The 1st Provisional Marine Brigade, 1950 by Hammes, T, Thomas X. Hammes

Potential for bispecific T-cell engagers: role of blinatumomab in acute lymphoblastic leukemia by Le Jeune C, Thomas X

Get full text

Toward Development of the Male Pill: A Decade of Potential Non-hormonal Contraceptive Targets by Katarzyna Kent, Katarzyna Kent, Katarzyna Kent, Madelaine Johnston, Madelaine Johnston, Natasha Strump, Natasha Strump, Thomas X. Garcia, Thomas X. Garcia, Thomas X. Garcia

Get full text

Continuidad y cambio. Problemas de la neolitización en el este de la Península Ibérica by Thomas X. Schuhmacher, Gerd- C. Weniger

Get full text

Recensiones y Crónica Científica by Thomas X. Schumacher, Irina Podgorny, Teresa Chapa Brunet, Victorino Mayoral Herrera, Oscar García Vuelta

Get full text

A New Model of Spontaneous Colitis in Mice Induced by Deletion of an RNA m6A Methyltransferase Component METTL14 in T CellsSummary by Thomas X. Lu, Zhong Zheng, Linda Zhang, Hui-Lung Sun, Marc Bissonnette, Haochu Huang, Chuan He

Get full text

CRISPR/Cas9-mediated genome editing reveals 12 testis-enriched genes dispensable for male fertility in mice by Yuki Oyama, Haruhiko Miyata, Keisuke Shimada, Yoshitaka Fujihara, Keizo Tokuhiro, Thomas X Garcia, Martin M Matzuk, Masahito Ikawa

Get full text

Colonial history and contemporary transmission shape the genetic diversity of hepatitis C virus genotype 2 in Amsterdam. by Markov, P, van de Laar, T, Thomas, X, Aronson, S, Weegink, C, van den Berk, G, Prins, M, Pybus, O, Schinkel, J

Molecular dissection and testing of PRSS37 function through LC–MS/MS and the generation of a PRSS37 humanized mouse model by Courtney Sutton, Kaori Nozawa, Katarzyna Kent, Alexander Saltzman, Mei Leng, Sureshbabu Nagarajan, Anna Malovannaya, Masahito Ikawa, Thomas X. Garcia, Martin M. Matzuk

Get full text

Origin and evolution of the unique hepatitis C virus circulating recombinant form 2k/1b by Raghwani, J, Thomas, X, Koekkoek, S, Schinkel, J, Molenkamp, R, van de Laar, T, Takebe, Y, Tanaka, Y, Mizokami, M, Rambaut, A, Pybus, O

Origin and evolution of the unique hepatitis C virus circulating recombinant form 2k/1b. by Raghwani, J, Thomas, X, Koekkoek, S, Schinkel, J, Molenkamp, R, van de Laar, T, Takebe, Y, Tanaka, Y, Mizokami, M, Rambaut, A, Pybus, O

Targeted ablation of miR-21 decreases murine eosinophil progenitor cell growth. by Thomas X Lu, Eun-Jin Lim, Svetlana Itskovich, John A Besse, Andrew J Plassard, Melissa K Mingler, Joelle A Rothenberg, Patricia C Fulkerson, Bruce J Aronow, Marc E Rothenberg

Get full text

Large-scale discovery of male reproductive tract-specific genes through analysis of RNA-seq datasets by Matthew J. Robertson, Katarzyna Kent, Nathan Tharp, Kaori Nozawa, Laura Dean, Michelle Mathew, Sandra L. Grimm, Zhifeng Yu, Christine Légaré, Yoshitaka Fujihara, Masahito Ikawa, Robert Sullivan, Cristian Coarfa, Martin M. Matzuk, Thomas X. Garcia

Get full text

The testis-specific E3 ubiquitin ligase RNF133 is required for fecundity in mice by Kaori Nozawa, Yoshitaka Fujihara, Darius J. Devlin, Ricardo E. Deras, Katarzyna Kent, Irina V. Larina, Kohei Umezu, Zhifeng Yu, Courtney M. Sutton, Qiuji Ye, Laura K. Dean, Chihiro Emori, Masahito Ikawa, Thomas X. Garcia, Martin M. Matzuk

Get full text

A phase 3 study of Enasidenib (ENA) versus conventional care regimens (CCR) in older patients with late-stage mutant-IDH2 (MIDH2) relapsed/refractory acute myeloid leukemia (R/R AM... by Papayannidis, C, DiNardo, C, Montesinos, P, Schuh, A, Vyas, P, Wei, A, Ommen, H, Semochkin, S, Kim, H, Larson, R, Koprivnikar, J, Frankfurt, O, Thol, F, Chromik, J, Byrne, J, Pigneux, A, Thomas, X, Salamero, O, Vidriales, M, Doronin, V, Dohner, H, Fathi, A, Laille, E, Yu, X, Hasan, M, Martin-Regueira, P, de Botton, S

Enasidenib vs conventional care in older patients with late-stage mutant-IDH2 relapsed/refractory AML: a randomized phase 3 trial by de Botton, S, Montesinos, P, Schuh, AC, Papayannidis, C, Vyas, P, Wei, AH, Ommen, H, Semochkin, S, Kim, H-J, Larson, RA, Koprivnikar, J, Frankfurt, O, Thol, F, Chromik, J, Byrne, J, Pigneux, A, Thomas, X, Salamero, O, Vidriales, MB, Doronin, V, Döhner, H, Fathi, AT, Laille, E, Yu, X, Hasan, M, Martin-Regueira, P, DiNardo, CD

AML-262 Pivekimab Sunirine (PVEK, IMGN632) triplet with azacitidine and venetoclax shows broad activity in adverse genetic subsets of relapsed/refractory acute myeloid leukemia and... by Daver, N, Montesinos, P, Aribi, A, Martinelli, G, Altman, JK, Wang, ES, Roboz, GJ, Burke, PW, Gaidano, G, Walter, RB, Thomas, X, Jeyakumar, D, DeAngelo, DJ, Erba, HP, Todisco, E, Begna, K, Advani, A, Gastaud, L, de la Fuente, A, Curti, A, Mendez, LM, Vyas, P, Boissel, N, Vey, N, Recher, C, Longval, T, Platzbecker, U, Kapp-Schwörer, S, Schliemann, C, Konopleva, M, Torres, L, Sallman, DA, Marcucci, G, Marconi, G, Kantarjian, H, Sloss, CM, Malcolm, KE, Zweidler-McKay, PA, Sweet, K